IL-17D Monoklonaler Antikörper

IL-17D Monoklonal Antikörper für WB,ELISA

Wirt / Isotyp

Maus / IgG2b

Getestete Reaktivität

human und mehr (1)

Anwendung

WB, IHC, ELISA

Konjugation

Unkonjugiert

Publikationen

3

CloneNo.

1D7H4

Kat-Nr. : 66143-1-Ig

Synonyme

IL 17D, IL 27, IL17D, IL-17D, IL27, interleukin 17D, Interleukin 27

---

Galerie der Validierungsdaten

• 

  WB analysis of Recombinant protein using 66143-1-Ig

  Recombinant protein were subjected to SDS PAGE followed by western blot with 66143-1-Ig (IL-17D antibody) at dilution of 1:20000 incubated at room temperature for 1.5 hours.

---

Geprüfte Anwendungen

• Erfolgreiche Detektion in WB: Recombinant protein, Rekombinantes Protein Protein

Empfohlene Verdünnung

• Western Blot (WB): WB : 1:5000-1:50000

It is recommended that this reagent should be titrated in each testing system to obtain optimal results.

Sample-dependent, check data in validation data gallery

Veröffentlichte Anwendungen

• WB: See 3 publications below
• IHC: See 2 publications below

Produktinformation

66143-1-Ig bindet in WB, IHC, ELISA IL-17D und zeigt Reaktivität mit human

• Getestete Reaktivität: human
• In Publikationen genannte Reaktivität: human, Maus
• Wirt / Isotyp: Maus / IgG2b
• Klonalität: Monoklonal
• Typ: Antikörper
• Immunogen: IL-17D fusion protein Ag6762
• Vollständiger Name: interleukin 17D
• Berechnetes Molekulargewicht: 22 kDa
• Beobachtetes Molekulargewicht: 28 kDa
• GenBank-Zugangsnummer: BC036243
• Gene symbol: IL17D
• Gene ID (NCBI): 53342
• Konjugation: Unkonjugiert
• Form: Liquid
• Reinigungsmethode: Protein-A-Reinigung
• Lagerungspuffer: PBS mit 0.02% Natriumazid und 50% Glycerin pH 7.3.
• Lagerungsbedingungen: Bei -20°C lagern. Nach dem Versand ein Jahr lang stabil Aliquotieren ist bei -20^oC Lagerung nicht notwendig. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

IL17D is a secreted cytokine with homology to the IL-17 family of proteins. IL17D is preferentially expressed in skeletal muscle, brain, adipose tissue, heart, lung, and pancreas. The treatment of endothelial cells with IL17D has been shown to stimulate the production of other cytokines including IL6, IL8 and CSF2/ GM-CSF. The increased expression of IL8 induced by IL17D was found to be NF-kappa B-dependent.

Publikationen

Species	Application	Title
human，mouse	WB	Biomed Pharmacother; Ruyiping extract reduces lung metastasis in triple negative breast cancer by regulating macrophage polarization.; Authors - Rui Yang
human	IHC, WB	Toxicology; Nuclear factor erythroid 2-related factor 2 potentiates the generation of inflammatory cytokines by intestinal epithelial cells during hyperoxia by inducing the expression of interleukin 17D.; Authors - Xuying Liu
human	WB,IHC	Int Immunopharmacol; ROS-activated MAPK/ERK pathway regulates crosstalk between Nrf2 and Hif-1α to promote IL-17D expression protecting the intestinal epithelial barrier under hyperoxia; Authors - Pingchuan Wang